CTOs on the Move

Alkeus Pharmaceuticals, Inc.

www.alkeuspharma.com

 
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

ME and A

ME&A is an international development firm based in the Washington, DC area, providing innovative solutions for economic development and social progress in more than 70 countries worldwide. ME&A is a 30-year old business with branch offices in Armenia, El Salvador, Georgia, Tanzania, Puerto Rico and Washington, DC.

Berk, Merchant and Sims, Plc

Berk, Merchant and Sims, Plc is a Miami, FL-based company in the Business Services sector.

Outside In

Outside In is a medical and youth service nonprofit organization in Portland, Oregon which provides primary care and "wraparound services" for low income and homeless clients.

SupplyStaff

SupplyStaff is a San Francisco, CA-based company in the Business Services sector.

Ken-A-Vision

Ken-A-Vision is a Kansas City, MO-based company in the Business Services sector.